Ubrogepant Drug Interactions
Currently displaying a list of 247 drugs known to interact with ubrogepant.
- 38 major drug interactions
- 208 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with ubrogepant
Note: Showing generic names only.
A
- abametapir topical
- abrocitinib
- acalabrutinib
- adagrasib
- afatinib
- alpelisib
- aminoglutethimide
- amiodarone
- amlodipine
- amobarbital
- amprenavir
- apalutamide
- aprepitant
- armodafinil
- asciminib
- atazanavir
- avacopan
- azithromycin
B
- belzutifan
- bepridil
- berotralstat
- bexarotene
- bicalutamide
- boceprevir
- bosentan
- brigatinib
- butabarbital
- butalbital
C
- cabozantinib
- canagliflozin
- cannabidiol
- capivasertib
- capmatinib
- carbamazepine
- carvedilol
- cenobamate
- ceritinib
- chloramphenicol
- cimetidine
- ciprofloxacin
- clarithromycin
- clofazimine
- clopidogrel
- clotrimazole
- cobicistat
- conivaptan
- crizotinib
- cyclosporine
D
- dabrafenib
- daclatasvir
- danazol
- danicopan
- daridorexant
- darolutamide
- darunavir
- dasatinib
- delavirdine
- dexamethasone
- diltiazem
- dronedarone
- duvelisib
E
- echinacea
- efavirenz
- elacestrant
- elafibranor
- elagolix
- eliglustat
- eltrombopag
- eluxadoline
- enasidenib
- encorafenib
- entrectinib
- enzalutamide
- erdafitinib
- erythromycin
- eslicarbazepine
- etravirine
F
- febuxostat
- fedratinib
- felbamate
- fenfluramine
- fexinidazole
- flibanserin
- fluconazole
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fosphenytoin
- fostamatinib
- fostemsavir
- futibatinib
G
H
I
- ibrutinib
- idelalisib
- imatinib
- indinavir
- iptacopan
- isavuconazonium
- isoniazid
- istradefylline
- itraconazole
- ivacaftor
- ivosidenib
K
L
- lapatinib
- larotrectinib
- lasmiditan
- lazertinib
- lefamulin
- lenacapavir
- leniolisib
- lesinurad
- letermovir
- levacetylleucine
- levamlodipine
- levoketoconazole
- lomitapide
- lonafarnib
- lonapegsomatropin
- lorlatinib
M
- maribavir
- mavacamten
- mavorixafor
- mephobarbital
- metreleptin
- mibefradil
- miconazole
- midostaurin
- mifepristone
- mirabegron
- mitapivat
- mitotane
- mobocertinib
- modafinil
- momelotinib
N
- nafcillin
- nefazodone
- nelfinavir
- neratinib
- nevirapine
- nicardipine
- nifedipine
- nilotinib
- niraparib
- nirogacestat
O
- olaparib
- olutasidenib
- omaveloxolone
- oritavancin
- osilodrostat
- osimertinib
- oteseconazole
- oxcarbazepine
P
- pacritinib
- palbociclib
- pazopanib
- pemigatinib
- pentobarbital
- pexidartinib
- phenobarbital
- phenytoin
- pirtobrutinib
- pitolisant
- ponatinib
- posaconazole
- pralsetinib
- pretomanid
- primidone
- progesterone
- propafenone
Q
R
- ranolazine
- regorafenib
- remdesivir
- repotrectinib
- resmetirom
- ribociclib
- rifabutin
- rifampin
- rifapentine
- ripretinib
- ritlecitinib
- ritonavir
- rolapitant
- rucaparib
- rufinamide
S
- safinamide
- saquinavir
- sarecycline
- secobarbital
- selpercatinib
- simeprevir
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sonidegib
- sorafenib
- sotorasib
- sparsentan
- spironolactone
- st. john's wort
- stiripentol
- suvorexant
- suzetrigine
T
- tacrolimus
- tafamidis
- tamoxifen
- tazemetostat
- tecovirimat
- tedizolid
- telaprevir
- telithromycin
- telotristat
- tepotinib
- teriflunomide
- ticagrelor
- tivozanib
- tolvaptan
- tovorafenib
- treosulfan
- trofinetide
- troglitazone
- troleandomycin
- tucatinib
U
V
- valbenazine
- vandetanib
- vemurafenib
- venetoclax
- verapamil
- viloxazine
- vimseltinib
- voclosporin
- vonoprazan
- vorasidenib
- voriconazole
- voxelotor
Z
Ubrogepant alcohol/food interactions
There is 1 alcohol/food interaction with ubrogepant.
Ubrogepant disease interactions
There are 2 disease interactions with ubrogepant which include:
More about ubrogepant
- ubrogepant consumer information
- Check interactions
- Compare alternatives
- Reviews (268)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CGRP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.